DL-Protect


Biogen announces $5 billion buyback days after shelving Alzheimers...






(Reuters) - Biogen Inc said on Monday it would buy back shares worth $5 billion, days after its stock slumped on the drugmaker’s announcement to end two Alzheimer’s disease trials.

Biogen had lost more than $18 billion of its value last week after the company and partner Eisai Co Ltd ended two late-stage trials of their experimental Alzheimer’s disease treatment, aducanumab.

Read more

Boeing to brief on 737 MAX updates as Ethiopian backs planemaker






ADDIS ABABA/SINGAPORE (Reuters) - Boeing Co will brief more than 200 global airline pilots, technical experts and regulators this week on software and training updates for its 737 MAX aircraft, as Ethiopian Airlines expressed confidence in the planemaker despite a recent crash.

Africa’s biggest carrier will work with Boeing and other airlines to make air travel safer, its chief executive, Tewolde Gebremariam, said, after regulators this month grounded the worldwide fleet of the aircraft following the crash that killed 157 people.

Read more